Histology of the Pharyngeal Constrictor Muscle in 22q11.2 Deletion Syndrome and Non-Syndromic Children with Velopharyngeal Insufficiency

Plastic surgeons aim to correct velopharyngeal insufficiency manifest by hypernasal speech with a velopharyngoplasty. The functional outcome has been reported to be worse in patients with 22q11.2 deletion syndrome than in patients without the syndrome. A possible explanation is the hypotonia that is often present as part of the syndrome. To confirm a myogenic component of the etiology of velopharyngeal insufficiency in children with 22q11.2 deletion syndrome, specimens of the pharyngeal constrictor muscle were taken from children with and without the syndrome. Histologic properties were compared between the groups. Specimens from the two groups did not differ regarding the presence of increased perimysial or endomysial space, fiber grouping by size or type, internalized nuclei, the percentage type I fibers, or the diameters of type I and type II fibers. In conclusion, a myogenic component of the etiology of velopharyngeal insufficiency in children with 22q11.2 deletion syndrome could not be confirmed

Cytomégalovirus et grossesse : Risque fœtal et néonatal

A review of the literature shows that 36% of pregnant women are not immunized against cytomegalovirus; 2.11% of these patients will have a primary infection during their pregnancy. The fetal transmission rate is 30%. Viruria after delivery is the unique proven sign of infection; but is only present in 4 to 5 infants per 1,000 births. Of those, 17% will be symptomatic at delivery and 10% will develop sequels as late as seven years later. CMV can be reactivated during pregnancy. These cases are less dangerous but the fetal risk is always present

Cytomégalovirus et foetus.

The literature on the risks to the fetus and neonate of maternal cytomegalovirus infection, whether primary or reactivated, is briefly reviewed. The various rates of risks reported and the mechanism of fetal infection are discussed. Screening for maternal infection, antenatal diagnosis of fetal infection, and development of new antiviral treatments and immunizations are advocated

Reproductive toxicity of dietary zinc to <i>Daphnia magna</i>

Regulatory assessments of metals in freshwaters are mostly based on dissolved metal concentrations, assuming that toxicity is caused by waterborne metal only. Little attention has been directed to the toxicity of dietary metals to freshwater invertebrates. In this study the chronic toxicity of dietary zinc to Daphnia magna was investigated. The green alga Pseudokirchneriella subcapitata was exposed for 64 h to a control and three dissolved zinc concentrations, i.e. 23, 28 and 61 µg L-1, resulting in internal zinc burdens in the algae of 130, 200, 320 and 490 µg g-1 dry weight, respectively. These algae were used as a food source in chronic, 21-day bioassays with D. magna in a test medium to which no dissolved zinc was added. None of the treatments resulted in effects on feeding rates or somatic growth of D. magna. In contrast, a significant 40% decrease of total reproduction (number of juveniles per adult) was observed in the 28 and 61 µg L-1 treatments. Time to first brood was not affected, whereas the mean brood size and the fraction of reproducing parent daphnids were reduced from the second brood onwards and the magnitude of these reductions increased with each subsequent brood. The reduced reproduction was accompanied with an elevated zinc accumulation in the 61 µg L-1 treatment only, suggesting that total body burden is no good indicator of dietary zinc toxicity. Overall our data suggest that dietary zinc specifically targets reproduction in D. magna through accumulation in particular target sites, possibly cells or tissues where vitellogenin synthesis or processing occur. Further, our data illustrate that the potential importance of the dietary exposure route should be carefully considered and interpreted in regulatory assessments of zinc

Prenatal diagnosis of fetal cytomegalovirus infection.

A prospective study (1988 to 1990) to evaluate the risk of fetal cytomegalovirus transmission was conducted with 1771 pregnant women; the test results of 861 were seronegative (48.6%). At each prenatal visit they were tested for serologic data and cytomegalovirus excretion in urine, saliva, and cervical secretions. If seroconversion occurred (with or without cytomegalovirus excretion), ultrasonography, amniocentesis, and cordocentesis were performed at 22 weeks' gestation; 7 cases of primary cytomegalovirus infection were investigated. In 5 cases the amniotic fluid cultures were positive; in 3 cases the fetal blood test results were positive for specific immunoglobulin M; and in 2 cases brain ultrasonography results were positive. Infection was confirmed with biopsies of fetal tissue. In two other cases, the cord blood and amniotic fluid test results were negative, and the neonates were free of infection